Key facts
- This page summarizes William P. Forbes's Form 4 filing for HERON THERAPEUTICS, INC. /DE/ (HRTX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 21 Oct 2026, 12:01.
William P. Forbes - 19 Oct 2026 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)
- Reporting relationship
- EVP, Chief Development Officer
- Issuer ticker
- HRTX
- Reported as of
- 19 Oct 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 21 Oct 2026, 12:01:59 UTC
- Prior SEC filing
- 03 Aug 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/Kathryn Lester Attorney-in-fact for William P. Forbes
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
William P. Forbes filed Form 4 for HERON THERAPEUTICS, INC. /DE/ (HRTX) on 21 Oct 2026.
Change
- Previous filing in this sequence was filed on 03 Aug 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001314760
Primary reporting owner
Forbes William P
- Relationship
- EVP, Chief Development Officer
- Address
- 25 FENTON MAIN STREET, SUITE 300, CARY
- Signature
- /s/Kathryn Lester Attorney-in-fact for William P. Forbes
- Signature date
- 21 Oct 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HRTX
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +3,874
- Change %
- +1.6%
- Price
- Shares after
- 245,047
- Date
- 19 Oct 2026
- Ownership
- Direct
- Footnotes
- F1
HRTX
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -1,102
- Change %
- -0.45%
- Price
- $0.3600*
- Shares after
- 243,945
- Date
- 19 Oct 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HRTX
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -3,874
- Change %
- -17%
- Price
- $0.000000*
- Shares after
- 19,372
- Date
- 19 Oct 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,874
- Exercise price
- $0.000000
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of common stock.
Footnote F2
The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).